相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cytoprotective Mechanisms of DJ-1: Implications in Cardiac Pathophysiology
James N. Tsoporis et al.
MOLECULES (2021)
The use of the soluble receptor for advanced glycation-end products (sRAGE) as a potential biomarker of disease risk and adverse outcomes
Jorge D. Erusalimsky
REDOX BIOLOGY (2021)
Is there any evidence that AGE/sRAGE is a universal biomarker/risk marker for diseases?
Kailash Prasad
MOLECULAR AND CELLULAR BIOCHEMISTRY (2019)
The soluble receptor for advanced glycation end-products (sRAGE) has a dual phase-dependent association with residual cardiovascular risk after an acute coronary event
Helena Grauen Larsen et al.
ATHEROSCLEROSIS (2019)
DJ-1 activates autophagy in the repression of cardiac hypertrophy
Ruicong Xue et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2017)
Enhanced S100A9 and S100A12 expression in acute coronary syndrome
Zafer Buyukterzi et al.
BIOMARKERS IN MEDICINE (2017)
Cardiovascular disease in Europe: epidemiological update 2016
Nick Townsend et al.
EUROPEAN HEART JOURNAL (2016)
DJ-1 Mediates the Delayed Cardioprotection of Hypoxic Preconditioning Through Activation of Nrf2 and Subsequent Upregulation of Antioxidative Enzymes
Yu-Feng Yan et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2015)
EN-RAGE A Novel Inflammatory Marker for Incident Coronary Heart Disease
Symen Ligthart et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Circulating soluble RAGE as a predictive biomarker of cardiovascular event risk in patients with type 2 diabetes
Keiko Fujisawa et al.
ATHEROSCLEROSIS (2013)
sRAGE and Risk of Diabetes, Cardiovascular Disease, and Death
Elizabeth Selvin et al.
DIABETES (2013)
Parkinson-susceptibility gene DJ-1/PARK7 protects the murine heart from oxidative damage in vivo
Filio Billia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
S100A12 as a Marker to Predict Cardiovascular Events in Patients With Chronic Coronary Artery Disease
Toshinobu Saito et al.
CIRCULATION JOURNAL (2012)
Adiponectin is inversely associated with ratio of serum levels of AGEs to sRAGE and vascular inflammation
Nobuhiro Tahara et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2012)
Association of serum soluble Receptor for Advanced Glycation End-products with subclinical cerebrovascular disease: The Northern Manhattan Study (NOMAS)
Barry I. Hudson et al.
ATHEROSCLEROSIS (2011)
Association of increased S100B, S100A6 and S100P in serum levels with acute coronary syndrome and also with the severity of myocardial infarction in cardiac tissue of rat models with ischemia-reperfusion injury
Xue Ying Cai et al.
ATHEROSCLEROSIS (2011)
The RAGE Axis A Fundamental Mechanism Signaling Danger to the Vulnerable Vasculature
Shi Fang Yan et al.
CIRCULATION RESEARCH (2010)
Higher Plasma Soluble Receptor for Advanced Glycation End Products (sRAGE) Levels Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes A 12-Year Follow-Up Study
Johanna W. M. Nin et al.
DIABETES (2010)
Binding of S100 proteins to RAGE: An update
Estelle Leclerc et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)
S100B's double life: Intracellular regulator and extracellular signal
Rosario Donato et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)
Association Between Circulating Soluble Receptor for Advanced Glycation End Products and Atherosclerosis Observations from the Dallas Heart Study
Jason B. Lindsey et al.
DIABETES CARE (2009)
Oxidative stress induction of DJ-1 protein in reactive astrocytes scavenges free radicals and reduces cell injury
Takashi Yanagida et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2009)
Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications
Giuseppina Basta
ATHEROSCLEROSIS (2008)
Decreased plasma soluble RAGE in patients with hypercholesterolemia:: Effects of statins
Francesca Santilli et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Soluble receptor for advanced glycation end products in patients with decreased renal function
M Kalousová et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2006)
Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension
D Geroldi et al.
JOURNAL OF HYPERTENSION (2005)
Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men
C Falcone et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Increased serum concentrations of soluble receptor for advanced glycation endproducts in patients with type 1 diabetes
M Challier et al.
CLINICAL CHEMISTRY (2005)
Increased coronary arterial release of interleukin-1 receptor antagonist and soluble CD40 ligand indicative of inflammation associated with culprit coronary plaques
A Aggarwal et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Role of oxidative modifications in atherosclerosis
R Stocker et al.
PHYSIOLOGICAL REVIEWS (2004)
Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells
P Calabró et al.
CIRCULATION (2003)
Involvement of C-reactive protein obtained by directional coronary atherectomy in plaque instability and developing restenosis in patients with stable or unstable angina pectoris
T Ishikawa et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Widespread coronary inflammation in unstable angina
A Buffon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Advanced glycation end products activate endothelium through signal-transduction receptor RAGE - A mechanism for amplification of inflammatory responses
G Basta et al.
CIRCULATION (2002)
分享论文
